Browse > Article

Surfactant Effects upon Dissolution Patterns of Carbamazepine Immediate Release Tablet  

Lee Hyeontae (Dept. of Pharmaceutical Sciences, College of Pharmacy, Catholic University)
Park Sang-Ae (Korea Food & Drug Administration)
Sah Hongkee (Dept. of Pharmaceutical Sciences, College of Pharmacy, Catholic University)
Publication Information
Archives of Pharmacal Research / v.28, no.1, 2005 , pp. 120-126 More about this Journal
Abstract
The objective of this study was to investigate the effects of sodium lauryl sulfate upon the saturation solubility of carbamazepine, its dissolution kinetics, and $T_{50\%}$ defined as the time required for dissolving $50\%$ of carbamazepine. Water, 0.1N-HCI, and phosphate buffers at pH 4.0 and 6.8 containing 0.1, 0.5, 1, and $2\%$ sodium lauryl sulfate were used as dissolution media. The dissolution study was conducted by using the USP dissolution apparatus II with an agitation rate of 75 rpm. Samples of the dissolution media were taken in 7, 15, 30, 45, 60, 75, and 90 min, and the amounts of carbamazepine were determined spectrophotometrically at 285 nm. All dissolution data were fitted well into a four-parameter exponential equation: $Q\;=\;a(1\;-\;e^{-bxt})\;+\;c(1\;-\;e^{-dxt})$. In this equation Q represented $\%$ carbamazepine dissolved at a time t, and a, b, c, and d were constants. This equation led to the calculation of dissolution rates at various time points and $T_{50\%}$. It was found that the dissolution rate of carbamazepine was directly proportional to the aqueous concentration of sodium lauryl sulfate. In addition, under our experimental conditions $T_{50%}$ values ranged from 37.8 to 4.9 min. It was interesting to note that $T_{50\%}$ declined rapidly as the surfactant concentration increased from 0.1 to $0.5\%$, whereas it declined more slowly at concentrations greater than $1\%$. These results clearly demonstrated that the dissolution rate of carbamazepine and duration of its dissolution test could be tailored by optimizing the amount of sodium lauryl sulfate in a dissolution medium.
Keywords
Dissolution test; Dissolution kinetics; Carbamazepine; Sodium lauryl sulfate;
Citations & Related Records

Times Cited By Web Of Science : 14  (Related Records In Web of Science)
Times Cited By SCOPUS : 9
연도 인용수 순위
1 Aunins, J. G., Southard, M., Meyers, R. A., Hemmelstein, K. J., and Stella, V. J., Dissolution of carboxylic acids III. The effect of polyionizable buffers. J. Pharm. Sci., 74, 1305-1316 (1985)   DOI   PUBMED
2 Castillo, J. A., Palomo-Canales, J., Garcia, J. J., Lastres, J. L., Bolas, F., and Torrado, J. J., Preparation and characterization of albendazole ${\beta}$-cyclodextrin complexes. Drug Dev. Ind. Pharm., 25, 1241-1248 (1999)   DOI   ScienceOn
3 FDA, Center for Drug Evaluation and Research. Guidance for Industry - SUPAC-MR: Modified release solid oral dosage forms: Scale-up and postapproval changes: Chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation, September 1997a
4 Jain, A. C. and Adeyeye, M. C., Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether ${\beta}$- cyclodextrins (SBE) and danazol-SBE inclusion complexes. Int. J. Pharm., 212, 177-186 (2001)   DOI   ScienceOn
5 Serajuddin, A. T. and Rosoff, M., pH-solubility profile of papaverine hydrochloride and its relationship to the dissolution rate of sustained-release pellets. J. Pharm. Sci., 73, 1203-1208 (1984)   DOI   PUBMED
6 Costa, P. and Lobo, J. M. S., Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev. Ind. Pharm., 27, 811-817 (2001)   DOI   ScienceOn
7 Langernbucher, F., Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol., 24, 979-981 (1972)   DOI
8 Qazi, S., Peter Samuel, N. K., Venkatachalam, T. K., and Uckun, F. M., Evaluating dissolution profiles of an anti-HIV agent using ANOVA and non-linear regression models in JMP software. Int. J. Pharm., 252, 27-39 (2003)   DOI   PUBMED   ScienceOn
9 Dawoodbhai, S. et al., Optimization of tablet formulation talc. Drug Dev. Ind. Pharm., 17, 1343-1371 (1991)   DOI
10 Abrahamsson, B., Johansson, D., Torstensson, A., and Wingstrand, K., Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine. Pharm. Res., 11, 1093-1097 (1994)   DOI   ScienceOn
11 Shah, V. P., Konecny, J. J., Everett, R. L., McCullough, B., Noorizadeh, A. C., and Skelly, J. P., In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm. Res., 6, 612-618 (1989)   DOI   ScienceOn
12 Velasco-De-Paola, M. V. R., Santoro, M. I. R. M., and Gai, M. N., Dissolution kinetics evaluation of controlled-release tablets containing propranolol hydrochloride. Drug Dev. Ind. Pharm., 25, 535-541 (1999)   DOI   ScienceOn
13 FDA, Center for Drug Evaluation and Research. Guidance for Industry - Extended release oral dosage forms: development, evaluation and application of in vitro/in vivo correlation, September 1997b
14 Sun, W., Larive, C. K., and Southard, M. Z., A mechanistic study of danazol dissolution in ionic surfactant solutions. J. Pharm. Sci., 92, 424-435 (2003)   DOI   ScienceOn
15 FDA, Center for Drug Evaluation and Research. Guidance for Industry - Immediate release solid dosage forms: Scale-up and postapproval changes (SUPAC-IR): Chemistry, manufacturing, and controls, in vitro dissolution testing and in vivo bioequivalence test documentation, November, 1995
16 Crison, J. R., Weiner, N. D., and Amidon, G. L., Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate. J. Pharm. Sci., 86, 384-388 (1997)   DOI   ScienceOn
17 Chen, L. R., Wesley, J. A., Bhattachar, S., Ruiz, B., Bahash, K., and Babu, S. R., Dissolution behavior of a poorly water soluble compound in the presence of Tween 80. Pharm. Res., 20, 797-801 (2003)   DOI   ScienceOn
18 Pena Romero, A. et al., Water uptake and force development in an optimized prolonged release formulation. Int. J. Pharm., 73, 239-248 (1991)   DOI   ScienceOn
19 Riegelman, S. and Collier, P., The application of statistical moment theory to the evaluation of the in vivo dissolution time and absorption time. J. Pharmacokient. Biopharm., 8, 509-534 (1980)   DOI   ScienceOn
20 Kervinen, L. and Yliruusi, J., Modelling S-shaped dissolution curves. Int. J. Pharm., 92, 115-122 (1993)   DOI   ScienceOn